Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Appointed director Quarterly results
|
Diffusion Pharmaceuticals Inc. (DFFN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/02/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
08/06/2019 |
4/A
| Adams Robert W (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns:
| Granted 19,200 options to buy
@ $3.15, valued at
$60.5k
|
|
08/06/2019 |
4/A
| Giles Mark T (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns:
| Granted 19,200 options to buy
@ $3.15, valued at
$60.5k
|
|
08/06/2019 |
4/A
| LEVIN ALAN G (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns:
| Granted 19,200 options to buy
@ $3.15, valued at
$60.5k
|
|
06/30/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
06/30/2017 |
4/A
| Gainer John (Chief Scientific Officer) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns:
| Granted 34,000 options to buy
@ $2.96, valued at
$100.6k
|
|
06/30/2017 |
4/A
| Shealy Ben (Sr VP Finance & Treasurer) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns:
| Granted 23,100 options to buy
@ $2.96, valued at
$68.4k
|
|
06/19/2014 |
4/A
| BARER SOL J (Chairman of the Board) has filed a Form 4 on RestorGenex Corp
Txns:
| Converted 270,616 shares
@ $2, valued at
$541.2k
Converted 78,473 shares
@ $2, valued at
$156.9k
Converted 76,755 shares
@ $2, valued at
$153.5k
Converted 126,894 shares
@ $2, valued at
$253.8k
|
|
|
|